Jane Street’s Champions Oncology CSBR Stock Holding History

Jane Street’s Portfolio CSBR Stock Details CSBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-17,667	Closed	-$130K	–	10899
2025 Q2	$130K	Sell	17,667 -5,353	-23%	-$37.8K	﹤0.01%	8834
2025 Q1	$200K	Buy	+23,020	New	+$233K	﹤0.01%	8452

Other funds holding CSBR

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAM

Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MBAM

Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jane Street's CSBR Position: Q3 2025 in Review

Jane Street sold out of Champions Oncology (CSBR) in Q3 2025, closing a stake of 17,667 shares — an estimated $130K sold.

Jane Street first reported a position in CSBR in Q1 2025 and held it in 2 quarters. The position peaked at $200K in Q1 2025. 27 funds tracked by Wall St. Rank hold CSBR as of Q3 2025.

Jane Street reported no remaining Champions Oncology position as of Q3 2025 after selling out during the quarter.
Jane Street sold 17,667 Champions Oncology shares in Q3 2025, an estimated $130K.
Jane Street first reported a position in Champions Oncology in Q1 2025 and held it in 2 quarters.
Jane Street's Champions Oncology position peaked at $200K in Q1 2025.
27 funds tracked by Wall St. Rank held Champions Oncology as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.